Axogen (AXGN) Stock: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$42.16
0.31 (0.74%)
▲
5d:
-10.49%
30d:
-15.12%
90d:
-0.47%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AXGN is fairly valued with market pricing in 1.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: AXGN is fairly valued with market pricing in 1.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.66
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $42.16, which is considered oversold relative to its 30-day fair value range of $45.50 to $50.51. The stock's valuation (Forward PE: 61.0) is in line with its historical norms (58.2). At these levels, the market is pricing in 1.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AXGN is in a strong uptrend. Immediate support is located at $39.62, while resistance sits at $52.43.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $53.90 (+27.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AXGN is in a strong uptrend. Immediate support is located at $39.62, while resistance sits at $52.43.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $53.90 (+27.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$45.50 -
$50.51
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Protect Your Profits
Holding AXGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.8% below Wall St target ($53.90)
- NEUTRAL: Market pricing in 1.6% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- CAUTION: 5-day price weakness (-10.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$45.50 -
$50.51
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$39.62
Resistance Level
$52.43
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
60.99
Wall Street Target
$53.90
(+27.8%)
Revenue Growth (YoY)
23.1%
Profit Margin
-13.4%
Valuation Premium vs History
+1.6% premium
PE vs Historical
61.0 vs 58.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.6%
(market-implied from PE analysis)
1-Year Target
$42.83
(+2%)
2-Year Target
$43.52
(+3%)
3-Year Target
$44.22
(+5%)
3-Yr Target (if PE normalizes)
(PE: 61→58)
PE COMPRESSION
$42.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 61.0, Growth: 54.5%)
$142.29
(+238%)
Base:
(SPY PE: 20.2, Growth: 54.5%)
$47.06
(+12%)
Bear:
(PE: 17.1, Growth: 54.5%)
$40.00
(-5%)
Share & Embed Analysis
Last updated: September 11, 2026 10:22 PM ET
Data refreshes hourly during market hours. Next update: 11:22 PM
Data refreshes hourly during market hours. Next update: 11:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
